The dipeptidyl peptidase IV family in cancer and cell biology

FEBS Journal

Volumn 277, Issue 5, 2010, Pages 1126-1144

  Yu, Denise M T ^a   Yao, Tsun Wen ^a   Chowdhury, Sumaiya ^a   Nadvi, Naveed A ^a,b   Osborne, Brenna ^a   Church, W Bret ^b   McCaughan, Geoffrey W ^a   Gorrell, Mark D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Dipeptidyl peptidase; Distribution; Enzyme; Extracellular matrix; Immune function; Liver fibrosis; Structure

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE; DIPEPTIDYL PEPTIDASE 10; DIPEPTIDYL PEPTIDASE 6; DIPEPTIDYL PEPTIDASE 8; DIPEPTIDYL PEPTIDASE 9; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ENZYME; FIBROBLAST ACTIVATION PROTEIN; SITAGLIPTIN; UNCLASSIFIED DRUG;

CELL TYPE; CYTOLOGY; DRUG TARGETING; ENZYME ACTIVITY; GENE STRUCTURE; HUMAN; IMMUNE RESPONSE; MOLECULAR RECOGNITION; MULTIGENE FAMILY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; MODELS, MOLECULAR; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

MAMMALIA;

EID: 76349097770     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07526.x     Document Type: Review

References (178)

1. Cunningham DF O'Connor B (1997) Proline specific peptidases. Biochim Biophys Acta 1343, 160 186.
2. Mentlein R (1988) Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett 234, 251 256.
3. Aertgeerts K, Levin I, Shi L, Snell GP, Jennings A, Prasad GS, Zhang Y, Kraus ML, Salakian S, Sridhar V et al. (2005) Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein Alpha. J Biol Chem 280, 19441 19444.
4. Edosada CY, Quan C, Tran T, Pham V, Wiesmann C, Fairbrother W Wolf BB (2006) Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett 580, 1581 1586.
5. Edosada CY, Quan C, Wiesmann C, Tran T, Sutherlin D, Reynolds M, Elliott JM, Raab H, Fairbrother W Wolf BB (2006) Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J Biol Chem 281, 7437 7444.
6. Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Muller E, Rettig WJ Gorrell MD (1999) Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 29, 1768 1778.
7. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ Rettig WJ (1999) Fibroblast activation protein: a dual-specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274, 36505 36512.
8. Abbott CA, Yu DMT, Woollatt E, Sutherland GR, McCaughan GW Gorrell MD (2000) Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem 267, 6140 6150.
9. Ajami K, Abbott CA, McCaughan GW Gorrell MD (2004) Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. Biochim Biophys Acta 1679, 18 28.
10. Lee HJ, Chen YS, Chou CY, Chien CH, Lin CH, Chang GG Chen X (2006) Investigation of the dimer interface and substrate specificity of prolyl dipeptidase DPP8. J Biol Chem 281, 38653 38662.
11. Bjelke JR, Christensen J, Nielsen PF, Branner S, Kanstrup AB, Wagtmann N Rasmussen HB (2006) Dipeptidyl peptidase 8 and 9 specificity and molecular characterization compared to dipeptidyl peptidase IV. Biochem J 396, 391 399.
12. Yu DMT, Ajami K, Gall MG, Park J, Lee CS, Evans KA, McLaughlin EA, Pitman MR, Abbott CA, McCaughan GW et al. (2009) The in vivo expression of dipeptidyl peptidases 8 and 9. J Histochem Cytochem 57, 1025 1040. doi: 10.1369/jhc.2009.953760.
13. Yu DMT, Wang XM, McCaughan GW Gorrell MD (2006) Extra-enzymatic functions of the dipeptidyl peptidase (DP) IV related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J 273, 2447 2461.
14. Nadal MS, Ozaita A, Amarillo Y, de Miera EV, Ma Y, Mo W, Goldberg EM, Misumi Y, Ikehara Y, Neubert TA et al. (2003) The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels. Neuron 37, 449 461.
15. Zagha E, Ozaita A, Chang SY, Nadal MS, Lin U, Saganich MJ, McCormack T, Akinsanya KO, Qi SY Rudy B (2005) Dipeptidyl peptidase 10 modulates Kv4-mediated A-type potassium channels. J Biol Chem 280, 18853 18861.
16. Li HL, Qu YJ, Lu YC, Bondarenko VE, Wang S, Skerrett IM Morales MJ (2006) DPP10 is an inactivation modulatory protein of Kv4.3 and Kv1.4. Am J Physiol Cell Physiol 291, C966 976.
17. Chen T, Ajami K, McCaughan GW, Gai W-P, Gorrell MD Abbott CA (2005) Molecular Characterization of a novel Dipeptidyl Peptidase Like 2 short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity. Biochim Biophys Acta 1764, 33 43.
18. Clark BD, Kwon E, Maffie J, Jeong HY, Nadal M, Strop P Rudy B (2008) DPP6 Localization in Brain Supports Function as a Kv4 Channel Associated Protein. Front Mol Neurosci 1, 8. doi: 10.3389/neuro.02.008.2008.
19. Strop P, Bankovich AJ, Hansen KC, Garcia KC Brunger AT (2004) Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J Mol Biol 343, 1055 1065.
20. McNicholas K, Chen T Abbott C (2009) Dipeptidyl peptidase (DP) 6 and DP10: novel brain proteins implicated in human health and disease. Clin Chem Lab Med 47, 262.
21. Kin Y, Misumi Y Ikehara Y (2001) Biosynthesis and characterization of the brain-specific membrane protein DPPX, a dipeptidyl peptidase IV-related protein. J Biochem 129, 289 295.
22. Hartel S, Gossrau R, Hanski C Reutter W (1988) Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry. Histochemistry 89, 151 161.
23. Gossrau R (1979) Histochemical and biochemical distribution of dipeptidyl peptidase IV (DP IV). Histochemistry 60, 231 248.
24. McCaughan GW, Wickson JE, Creswick PF Gorrell MD (1990) Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology 11, 534 544.
25. Gorrell MD, Wickson J McCaughan GW (1991) Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes. Cell Immunol 134, 205 215.
26. Carbone A, Gloghini A, Zagonel V, Aldinucci D, Gattei V, Degan M, Improta S, Sorio R, Monfardini S Pinto A (1995) The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 86, 4617 4626.
27. Dang NH, Aytac U, Sato K, O'Brien S, Melenhorst J, Morimoto C, Barrett AJ Molldrem JJ (2003) T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. Br J Haematol 121, 857 865.
28. Asada Y, Aratake Y, Kotani T, Marutsuka K, Araki Y, Ohtaki S Sumiyoshi A (1993) Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathology 23, 265 270.
29. Goscinski MA, Suo ZH, Nesland JM, Florenes VA Giercksky KE (2008) Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines. APMIS 116, 823 831.
30. Aratake Y, Kotani T, Tamura K, Araki Y, Kuribayashi T, Konoe K Ohtaki S (1991) Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol 96, 306 310.
31. Kehlen A, Lendeckel U, Dralle H, Langner J Hoang-Vu C (2003) Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res 63, 8500 8506.
32. Tanaka T, Umeki K, Yamamoto I, Sakamoto F, Noguchi S Ohtaki S (1995) CD26 (Dipeptidyl peptidase IV DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 64, 326 331.
33. Wilson MJ, Ruhland AR, Quast BJ, Reddy PK, Ewing SL Sinha AA (2000) Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl 21, 220 226.
34. Bauvois B, De Meester I, Dumont J, Rouillard D, Zhao HX Bosmans E (1999) Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. Br J Cancer 79, 1042 1048.
35. Cro L, Morabito F, Zucal N, Fabris S, Lionetti M, Cutrona G, Rossi F, Gentile M, Ferrario A, Ferrarini M et al. (2009) CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. Hematol Oncol 27, 140 147. doi: 10.1002/hon.888.
36. Matsumoto Y, Bishop GA McCaughan GW (1992) Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver. Hepatology 15, 1048 1053.
37. Khin EE, Kikkawa F, Ino K, Kajiyama H, Suzuki T, Shibata K, Tamakoshi K, Nagasaka T Mizutani S (2003) Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade. Am J Obstet Gynecol 188, 670 676. (Pubitemid 36332432)
38. Garin-Chesa P, Old LJ Rettig WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 87, 7235 7239.
39. Dolznig H, Schweifer N, Puri C, Kraut N, Rettig WJ, Kerjaschki D Garin-Chesa P (2005) Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin. Cancer Immunity 5, 10 18.
40. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, Albino AP Old LJ (1993) Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res 53, 3327 3335.
41. Collins PJ, McMahon G, O'Brien P O'Connor B (2004) Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol 36, 2320 2333.
42. Lee KN, Jackson KW, Christiansen VJ, Chung KH McKee PA (2004) A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood 103, 3783 3788.
43. Lee KN, Jackson KW, Christiansen VJ, Lee CS, Chun JG McKee PA (2006) Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 107, 1397 1404.
44. Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Godde S, Dinges H et al. (2006) Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther 8, R171.
45. Milner JM, Kevorkian L, Young DA, Jones D, Wait R, Donell ST, Barksby E, Patterson AM, Middleton J, Cravatt BF et al. (2006) Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther 8, R23. doi:10.1186/ar1877.
46. Brown DD, Wang Z, Furlow JD, Kanamori A, Schwartzman RA, Remo BF Pinder A (1996) The thyroid hormone-induced tail resorption program during Xenopus Laevis metamorphosis. Proc Natl Acad Sci USA 93, 1924 1929.
47. Niedermeyer J, Garin-Chesa P, Kriz M, Hilberg F, Mueller E, Bamberger U, Rettig WJ Schnapp A (2001) Expression of the fibroblast activation protein during mouse embryo development. Int J Dev Biol 45, 445 447.
48. Levy MT, McCaughan GW, Marinos G Gorrell MD (2002) Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver Int 22, 93 101.
49. Cox G, Kable E, Jones A, Fraser I, Manconi F Gorrell MD (2003) 3-dimensional imaging of collagen using second harmonic generation. J Struct Biol 141, 53 62.
50. Wang XM, Yu DMT, McCaughan GW Gorrell MD (2005) Fibroblast activation protein increases apoptosis, cell adhesion and migration by the LX-2 human stellate cell line. Hepatology 42, 935 945.
51. Rettig WJ (1998) Fibroblast activation protein. In Handbook of Proteolytic Enzymes (Barrett AJ, Rawlings ND Woessner JF eds pp. 387 389. Academic Press, San Diego.
52. Acharya PS, Zukas A, Chandan V, Katzenstein AL Pure E (2006) Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol 37, 352 360.
53. Mersmann M, Schmidt A, Rippmann JF, Wuest T, Brocks B, Rettig WJ, Garin-Chesa P, Pfizenmaier K Moosmayer D (2001) Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. Int J Cancer 92, 240 248.
54. Wuest T, Moosmayer D Pfizenmaier K (2001) Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein. J Biotechnol 92, 159 168.
55. Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ et al. (1994) Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol 12, 1193 1203.
56. Loeffler M, Kruger JA, Niethammer AG Reisfeld RA (2006) Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 116, 1955 1962.
57. Lee J, Fassnacht M, Nair S, Boczkowski D Gilboa E (2005) Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res 65, 11156 11163.
58. Adams S, Miller GT, Jesson MI, Watanabe T, Jones B Wallner BP (2004) PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res 64, 5471 5480.
59. Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee H-O, Wang H, Lai JH, Bachovchin WW Weiner LM (2005) Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Mol Cancer Ther 4, 351 360.
60. LeBeau AM, Brennen WN, Aggarwal S Denmeade SR (2009) Targeting cancer stroma with a fibroblast activation protein-activated promelittin protoxin. Mol Cancer Ther 8, 1378 1386.
61. Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD Zheng G (2009) Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J Med Chem 52, 358 368. doi:10.1021/jm801052f [pii].
62. Gorrell MD Yu DMT (2005) Diverse functions in a conserved structure: the dipeptidyl peptidase IV gene family. In Trends in Protein Research (Robinson JW ed pp 1 78. Nova Science Publishers, Inc., New York.
63. Schade J, Stephan M, Schmiedl A, Wagner L, Niestroj AJ, Demuth HU, Frerker N, Klemann C, Raber KA, Pabst R et al. (2008) Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats. J Histochem Cytochem 56, 147 155.
64. Dubois V, Ginneken CV, De Cock H, Lambeir A-M, Van der Veken P, Augustyns K, Chen X, Scharpé S De Meester I (2009) Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues. J Histochem Cytochem 57, 531 541. doi:10.1369/jhc.2009. 952739.
65. Frerker N, Wagner L, Wolf R, Heiser U, Hoffmann T, Rahfeld J-U, Schade J, Karla T, Naim HY, Alfalah M et al. (2007) Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 28, 257 268.
66. Stremenova J, Krepela E, Mares V, Trim J, Dbaly V, Marek J, Vanickova Z, Lisa V, Yea C Sedo A (2007) Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int J Oncol 31, 785 792.
67. Zhu H, Zhou ZM, Lu L, Xu M, Wang H, Li JM Sha JH (2005) Expression of a novel dipeptidyl peptidase 8 (DPP8) transcript variant, DPP8-v3, in human testis. Asian J Androl 7, 245 255.
68. Olsen C Wagtmann N (2002) Identification and characterization of human Dpp9, a novel homologue of dipeptidyl peptidase IV. Gene 299, 185 193.
69. Qi SY, Riviere PJ, Trojnar J, Junien JL Akinsanya KO (2003) Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases. Biochem J 373, 179 189.
70. Kurokawa Y, Matoba R, Takemasa I, Nakamori S, Tsujie M, Nagano H, Dono K, Umeshita K, Sakon M, Ueno N et al. (2003) Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J Hepatol 39, 1004 1012.
71. López-Otin C Matrisian LM (2007) Emerging roles of proteases in tumour suppression. Nature Rev Cancer 7, 800 808. doi: 10.1038/nrc2228.
72. Mentlein R, Gallwitz B Schmidt WE (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214, 829 835.
73. Deacon CF, Hughes TE Holst JJ (1998) Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes 47, 764 769.
74. Kirby MS, Yu DM, O'Connor SP Gorrell MD (2010) Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. Clin Sci 118, 31 41. doi: 10.1042/CS20090047.
75. Mentlein R (1999) Dipeptidyl-peptidase IV (CD26): role in the inactivation of regulatory peptides. Regul Pept 85, 9 24.
76. Dimitrijevic M, Stanojevic S, Mitic K, Kustrimovic N, Vujic V, Miletic T Kovacevic-Jovanovic V (2008) The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Peptides 29, 2179 2187. doi: 10.1016/j.peptides.2008.08.017.
77. Guieu R, Fenouillet E, Devaux C, Fajloun Z, Carrega L, Sabatier JM, Sauze N Marguet D (2006) CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity. Behav Brain Res 166, 230 235. doi: S0166-4328(05)00332-3.
78. Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP Houghton AN (1993) A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 177, 1135 1143.
79. De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P Scharpé S (1994) Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur J Immunol 24, 566 570.
80. Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, Dang NH, Schlossman SF Morimoto C (2001) CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci USA 98, 12138 12143.
81. Ohnuma K, Yamochi T, Uchiyama M, Nishibashi K, Yoshikawa N, Shimizu N, Iwata S, Tanaka H, Dang NH Morimoto C (2004) CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc Natl Acad Sci USA 101, 14186 14191.
82. Ohnuma K, Uchiyama M, Yamochi T, Nishibashi K, Hosono O, Takahashi N, Kina S, Tanaka H, Lin X, Dang NH et al. (2007) Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1. J Biol Chem 282, 10117 10131.
83. Piazza GA, Callanan HM, Mowery J Hixson DC (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262, 327 334.
84. Cheng HC, Abdel-Ghany M Pauli BU (2003) A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 278, 24600 24607.
85. Gonzalez-Gronow M, Grenett HE, Weber MR, Gawdi G Pizzo SV (2001) Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochem J 355, 397 407.
86. Girardi ACC, Degray BC, Nagy T, Biemesderfer D Aronson PS (2001) Association of Na+-H+ exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule. J Biol Chem 276, 46671 46677.
87. Davoodi J, Kelly J Gendron Nea (2007) The Simpson-Golabi-Behmel syndrome causative Glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics 7, 2300 2310.
88. Cheng HC, Abdel-Ghany M, Elble RC Pauli BU (1998) Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J Biol Chem 273, 24207 24215. (Pubitemid 28435768)
89. Gonzalez-Gronow M, Misra UK, Gawdi G Pizzo SV (2005) Association of plasminogen with dipeptidyl peptidase IV and Na+-H+ exchanger isoform NHE3 regulates invasion of human 1-LN prostate tumor cells. J Biol Chem 280, 27173 27178.
90. Wesley UV, Albino AP, Tiwari S Houghton AN (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190, 311 322.
91. Wesley UV, Tiwari S Houghton AN (2004) Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 109, 855 866.
92. Wesley UV, McGroarty M Homoyouni A (2005) Dipeptidyl Peptidase Inhibits Malignant Phenotype of Prostate Cancer Cells by Blocking Basic Fibroblast Growth Factor Signaling Pathway. Cancer Res 65, 1325 1334.
93. Arscott WT, LaBauve AE, May V Wesley UV (2009) Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. Oncogene 28, 479 491.
94. Kikkawa F, Kajiyama H, Ino K, Shibata K Mizutani S (2003) Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV. Int J Cancer 105, 779 783.
95. Pethiyagoda CL, Welch DR Fleming TP (2001) Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis 18, 391 400.
96. Sato T, Yamochi T, Aytac U, Ohnuma K, McKee KS, Morimoto C Dang NH (2005) CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299. Cancer Res 65, 6950 6956.
97. Yamochi T, Yamochi T, Aytac U, Sato T, Sato K, Ohnuma K, McKee KS, Morimoto C Dang NH (2005) Regulation of p38 phosphorylation and topoisomerase IIα expression in the B-cell lymphoma line Jiyoye by CD26/Dipeptidyl Peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin. Cancer Res 65, 1973 1983.
98. Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K Mizutani S (2003) Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res 63, 2278 2283.
99. Ohnuma K, Takahashi N, Yamochi T, Hosono O, Dang NH Morimoto C (2008) Role of CD26/dipeptidyl peptidase IV in human T cell activation and function. Front Biosci 13, 2299 2310.
100. Fleischer B (1987) A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J Immunol 138, 1346 1350.
101. Heike M, Mobius U, Knuth A, Meuer S Meyer-zum-Buschenfelde KH (1988) Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations. Clin Exp Immunol 74, 431 434.
102. Morimoto C, Torimoto Y, Levinson G, Rudd CE, Schrieber M, Dang NH, Letvin LN Schlossman SF (1989) 1F7, a novel cell surface molecule involved in helper function of CD4 cells. J Immunol 143, 3430 3435.
103. Marguet D, Bernard AM, Vivier I, Darmoul D, Naquet P Pierres M (1992) cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. J Biol Chem 267, 2200 2208.
104. Schön E Ansorge S (1990) Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes. Biol Chem Hoppe Seyler 371, 699 705.
105. Kähne T, Lendeckel U, Wrenger S, Neubert K, Ansorge S Reinhold D (1999) Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int J Mol Med 4, 3 15.
106. Bednarczyk JL, Carroll SM, Marin C McIntyre BW (1991) Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J Cell Biochem 46, 206 218.
107. Vanham G, Kestens L, De Meester I, Vingerhoets J, Penne G, Vanhoof G, Scharpé S, Heyligen H, Bosmans E, Ceuppens JL et al. (1993) Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J Acquir Immune Defic Syndr 6, 749 757.
108. Brezinschek RI, Lipsky PE, Galea P, Vita R Oppenheimermarks N (1995) Phenotypic characterization of CD4(+) T cells that exhibit a transendothelial migratory capacity. J Immunol 154, 3062 3077.
109. De Meester IA, Kestens LL, Vanham GL, Vanhoof GC, Vingerhoets JH, Gigase PL Scharpé SL (1995) Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling. J Leukoc Biol 58, 325 330.
110. Masuyama J, Yoshio T, Suzuki K, Kitagawa S, Iwamoto M, Kamimura T, Hirata D, Takeda A, Kano S Minota S (1999) Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers. J Exp Med 189, 979 990.
111. Willheim M, Ebner C, Baier K, Kern W, Schrattbauer K, Thien R, Kraft D, Breiteneder H, Reinisch W Scheiner O (1997) Cell surface characterization of T lymphocytes and allergen-specific T cell clones - correlation of CD26 expression with T-H1 subsets. J Allergy Clin Immunol 100, 348 355.
112. Rogge L, Bianchi E, Biffi M, Bono E, Chang SY, Alexander H, Santini C, Ferrari G, Sinigaglia L, Seiler M et al. (2000) Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet 25, 96 101.
113. Boonacker EP, Wierenga EA, Smits HH Van Noorden CJF (2002) CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry. J Histochem Cytochem 50, 1169 1177.
114. Riemann D, Hansen GH, Niels-Christiansen LL, Thorsen E, Immerdal L, Santos AN, Kehlen A, Langner J Danielsen EM (2001) Caveolae/lipid rafts in fibroblast-like synoviocytes: ectopeptidase-rich membrane microdomains. Biochem J 354, 47 55.
115. Slimane TA, Lenoir C, Bello V, Delaunay JL, Goding JW, Chwetzoff S, Maurice M, Fransen JAM Trugnan G (2001) The cytoplasmic/transmembrane domain of dipeptidyl peptidase IV, a type II glycoprotein, contains an apical targeting signal that does not specifically interact with lipid rafts. Exp Cell Res 270, 45 55.
116. Tanaka T, Kameoka J, Yaron A, Schlossman SF Morimoto C (1993) The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90, 4586 4590.
117. Martin M, Huguet J, Centelles JJ Franco R (1995) Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol 155, 4630 4643.
118. Morimoto C Schlossman SF (1998) The structure and function of CD26 in the T cell immune response. Immunol Rev 161, 55 70.
119. Hegen M, Kameoka J, Dong RP, Schlossman SF Morimoto C (1997) Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology 90, 257 264.
120. Kähne T, Neubert K, Faust J Ansorge S (1998) Early phosphorylation events induced by DPIV/CD26-specific inhibitors. Cell Immunol 189, 60 66.
121. Ohnuma K, Yamochi T, Uchiyama M, Nishibashi K, Iwata S, Hosono O, Kawasaki H, Tanaka H, Dang NH Morimoto C (2005) CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Mol Cell Biol 25, 7743 7757.
122. Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF Morimoto C (1994) Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 91, 3082 3086.
123. Schmitz T, Underwood R, Khiroya R, Bachovchin WW Huber BT (1996) Potentiation of the immune response in HIV-1(+) individuals. J Clin Invest 97, 1545 1549.
124. Hühn J, Ehrlich S, Fleischer B von Bonin A (2000) Molecular analysis of CD26-mediated signal transduction in T cells. Immunol Lett 72, 127 132.
125. Gorrell MD (2003) First bite. Nat Struct Biol 10, 3 5.
126. Vora KA, Porter G, Peng R, Cui Y, Pryor K, Eiermann G Zaller D (2009) Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses. BMC Immunol 10, 19.
127. Fleischer B, Sturm E, De-Vries JE Spits H (1988) Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. J Immunol 141, 1103 1107.
128. Dang NH, Torimoto Y, Sugita K, Daley JF, Schow P, Prado C, Schlossman SF Morimoto C (1990) Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol 145, 3963 3971.
129. Bühling F, Junker U, Reinhold D, Neubert K, Jager L Ansorge S (1995) Functional role of CD26 on human B lymphocytes. Immunol Lett 45, 47 51.
130. Yan SL, Marguet D, Dobers J, Reutter W Fan H (2003) Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur J Immunol 33, 1519 1527.
131. Busso N, Wagtmann N, Herling C, Chobaz-Peclat V, Bischof-Delaloye A, So A Grouzmann E (2005) Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166, 433 442.
132. Lee KN, Jackson KW, Terzyan S, Christiansen VJ McKee PA (2009) Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design. Biochemistry 48, 5149 5158. doi: 10.1021/bi900257m.
133. Mueller SC, Ghersi G, Akiyama SK, Sang QXA, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y Chen WT (1999) A novel protease-docking function of integrin at invadopodia. J Biol Chem 274, 24947 24952.
134. Artym VV, Kindzelskii AL, Chen WT Petty HR (2002) Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis 23, 1593 1601.
135. Aggarwal S, Brennen WN, Kole TP, Schneider E, Topaloglu O, Yates M, Cotter RJ Denmeade SR (2008) Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry 47, 1076 1086.
136. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P Houghton AN (2004) FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 23, 5435 5446.
137. Cheng JD, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK Weiner LM (2002) Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62, 4767 4772.
138. Gorrell MD (2007) Liver fibrosis: the hepatocyte revisited. Hepatology 46, 1659 1661.
139. Ajami K, Pitman MR, Wilson CH, Park J, Menz RI, Starr AE, Cox JH, Abbott CA, Overall CM Gorrell MD (2008) Inflammatory protein-10, interferon-inducible T cell chemo-attractant and stromal cell-derived factors 1α and 1β are novel substrates of dipeptidyl peptidase 8. FEBS Lett 582, 819 825. doi: 10.1016/j.febslet.2008.02.005.
140. Park J, Knott HM, Nadvi NA, Collyer CA, Wang XM, Church WB Gorrell MD (2008) Reversible inactivation of human dipeptidyl peptidases 8 and 9 by oxidation. Open Enzyme Inhib J 1, 52 61. doi: http://www.bentham.org/open/toeij/ openaccess2.htm.
141. Hildeman DA, Mitchell T, Kappler J Marrack P (2003) T cell apoptosis and reactive oxygen species. J Clin Invest 111, 575 581. (Pubitemid 36278573)
142. Poole L, Karplus P A C (2004) Protein Sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44, 325 347.
143. Rhee S (1999) Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31, 53 59.
144. Stone JR (2004) An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems. Arch Biochem Biophys 422, 119 124.
145. Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, Arthur MJ, Iredale JP Mann DA (2001) Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121, 685 698.
146. Bilodeau N, Fiset A, Poirier GG, Fortier S, Gingras M-C, Lavoie JN Faure RL (2006) Insulin-dependent phosphorylation of DPP IV in liver: evidence for a role of compartmentalized c-Src. FEBS J 273, 992 1003.
147. Blom N, Gammeltoft S Brunak S (1999) Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294, 1351 1362.
148. von Bonin A, Hühn J Fleischer B (1998) Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T cell activation pathway. Immunol Rev 161, 43 53.
149. Tanaka S, Murakami T, Horikawa H, Sugiura M, Kawashima K Sugita T (1997) Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int J Immunopharmacol 19, 15 24.
150. Jones B, Adams S, Miller GT, Jesson MI, Watanabe T Wallner BP (2003) Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies. Blood 102, 1641 1648.
151. Maes M-B, Dubois V, Brandt I, Lambeir A-M, Veken PVd, Augustyns K, Cheng JD, Chen X, Scharpé S Meester ID (2007) Dipeptidyl peptidase 8/9-like activity in human leukocytes. J Leukoc Biol 81, 1252 1257.
152. Lankas G, Leiting B, Roy R, Eiermann G, Beconi M, Biftu T, Chan C, Edmondson S, Feeney W, He H et al. (2005) Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes - Potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 54, 2988 2994.
153. Reinhold D, Goihl A, Wrenger S, Reinhold A, Kühlmann UC, Faust J, Neubert K, Thielitz A, Brocke S, Täger M et al. (2009) Role of dipeptidyl peptidase IV (DPIV)-like enzymes in T lymphocyte activation: investigations in DPIV/CD26 knockout mice. Clin Chem Lab Med 47, 268 274. doi: 10.1515/CCLM.2009.062.
154. Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ Wagtmann N (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci USA 97, 6874 6879.
155. Conarello S, Li Z, Ronan J, Roy R, Zhu L, Jiang G, Liu F, Woods J, Zycband E, Moller D et al. (2003) Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl Acad Sci USA 100, 6825 6830.
156. Shingu K, Helfritz A, Zielinska-Skowronek M, Meyer-Olson D, Jacobs R, Schmidt RE, Mentlein R, Pabst R von Horsten S (2003) CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26. Cancer Immunol Immunother 52, 546 554. doi: 10.1007/s00262-003-0392-9.
157. Klemann C, Schade J, Pabst R, Leitner S, Stiller J, von Horsten S Stephan M (2009) CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently. Clin Exp Immunol 155, 357 365. doi: 10.1111/j.1365-2249.2008.03839.x.
158. Niedermeyer J, Kriz M, Hilberg F, Garin-Chesa P, Bamberger U, Lenter MC, Park J, Viertel B, Puschner H, Mauz M et al. (2000) Targeted disruption of mouse fibroblast activation protein. Mol Cell Biol 20, 1089 1094.
159. Wang XM, Cordoba S, Marguet D, Rettig W, Schnapp A, McCaughan GW Gorrell MD (2007) Reduced hepatic fibrosis is associated with fewer intrahepatic B cells in Fibroblast Activation Protein and dipeptidyl peptidase IV gene knockout mice. Hepatology 46, 299A.
160. Pennisi A, Li X, Ling W, Khan S, Gaddy D, Suva LJ, Barlogie B, Shaughnessy JD, Aziz N Yaccoby S (2009) Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease. Br J Haematol 145, 775 787. doi: 10.1111/j.1365-2141.2009.07696.x.
161. Gaetaniello L, Fiore M, De Filippo S, Pozzi N, Tamasi S Pignata C (1998) Occupancy of Dipeptidyl Peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Hepatology 27, 934 942.
162. Rummey C Metz G (2007) Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site. Proteins 66, 160 171.
163. Rasmussen HB, Branner S, Wiberg FC Wagtmann N (2003) Crystal structure of human DPP-IV/CD26 in complex with a substrate analogue. Nat Struct Biol 10, 19 25.
164. Kirby MS (2008) In vitro enzymologic characteristics of saxagliptin, a highly potent and selective DPP4 inhibitor with 'slow binding' characteristics. Clin Chem Lab Med 46, A29.
165. Wu JJ, Tang HK, Yeh TK, Chen CM, Shy HS, Chu YR, Chien CH, Tsai TY, Huang YC, Huang YL et al. (2009) Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. Biochem Pharmacol 78, 203 210. doi: S10.1016/j.bcp.2009.03.032.
166. Rawlings ND, Morton FR, Kok CY, Kong J Barrett AJ (2008) MEROPS: the peptidase database. Nucleic Acids Res 36, D320 325. doi: gkm954 [pii]10.1093/nar/gkm954.
167. Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, Opdenakker G, De Clercq E, Scharpé S Van Damme J (1998) Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem 273, 7222 7227.
168. Lambeir AM, Proost P, Durinx C, Bal G, Senten K, Augustyns K, Scharpé S, Van Damme J De Meester I (2001) Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 276, 29839 29845.
169. Proost P, Struyf S, Loos T, Gouwy M, Schutyser E, Conings R, Ronsse I, Parmentier M, Grillet B, Opdenakker G et al. (2006) Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies. Arthritis Res Ther 8, R107.
170. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E Norcross MA (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation normal T cell expressed and activated) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 186, 1865 1872.
171. Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S et al. (2007) Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signalling and reduces lymphocyte and endothelial cell migration. Blood 110, 37 44.
172. Proost P, Struyf S, Schols D, Durinx C, Wuyts A, Lenaerts JP, De Clercq E, De Meester I Van Damme J (1998) Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett 432, 73 76.
173. Shioda T, Kato H, Ohnishi Y, Tashiro K, Ikegawa M, Nakayama EE, Hu H, Kato A, Sakai Y, Liu H et al. (1998) Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci USA 95, 6331 6336.
174. Proost P, Menten P, Struyf S, Schutyser E, De Meester I Van Damme J (2000) Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78 beta into a most efficient monocyte attractant and CCR1 agonist. Blood 96, 1674 1680.
175. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P Luster AD (1996) Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 2, 449 456.
176. Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpé S et al. (1999) CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162, 4903 4909.
177. Mantovani A, Gray PA, Van Damme J Sozzani S (2000) Macrophage-derived chemokine (MDC). J Leukoc Biol 68, 400 404.
178. Proost P, Struyf S, Schols D, Opdenakker G, Sozzani S, Allavena P, Mantovani A, Augustyns K, Bal G, Haemers A et al. (1999) Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J Biol Chem 274, 3988 3993.